86 related articles for article (PubMed ID: 2083359)
1. [Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography].
Tertov VV; Sobenin IA; Tonevitskiĭ AG; Orekhov AN
Biull Eksp Biol Med; 1990 Dec; 110(12):606-9. PubMed ID: 2083359
[TBL] [Abstract][Full Text] [Related]
2. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
[TBL] [Abstract][Full Text] [Related]
4. [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis].
Mukhin DN; Tertov VV; Kacharava AG; Orekhov AN
Biull Eksp Biol Med; 1990 Aug; 110(8):138-40. PubMed ID: 2291955
[TBL] [Abstract][Full Text] [Related]
5. Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
Tertov VV; Sobenin IA; Orekhov AN
Int J Tissue React; 1992; 14(4):155-62. PubMed ID: 1478792
[TBL] [Abstract][Full Text] [Related]
6. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
Tertov VV; Sobenin IA; Tonevitsky AG; Orekhov AN; Smirnov VN
Biochem Biophys Res Commun; 1990 Mar; 167(3):1122-7. PubMed ID: 2322261
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
Sobenin IA; Tertov VV; Orekhov AN
Int Angiol; 1994 Mar; 13(1):78-83. PubMed ID: 8077803
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
Kacharava AG; Tertov VV; Orekhov AN
Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
[TBL] [Abstract][Full Text] [Related]
9. [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].
Tertov VV; Sobenin IA; Gevara Kh; Morrisett DD; Orekhov AN
Kardiologiia; 1992 Sep; 32(9-10):57-61. PubMed ID: 1287315
[TBL] [Abstract][Full Text] [Related]
10. [Low density lipoproteins isolated from the blood of patients with ischemic heart disease induce accumulation of lipids in human aortic intima cells].
Tertov VV; Kacharava AG; Martseniuk ON; Mukhin DN; Rogova EM; Orekhov AN
Biull Eksp Biol Med; 1990 Feb; 109(2):117-9. PubMed ID: 2337636
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic modified LDL in diabetes.
Sobenin IA; Tertov VV; Orekhov AN
Diabetes; 1996 Jul; 45 Suppl 3():S35-9. PubMed ID: 8674887
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid content of low-density lipoprotein in women with coronary artery disease.
Lindbohm N; Gylling H; Rajaratnam RA; Miettinen TA
J Lab Clin Med; 2000 Aug; 136(2):110-5. PubMed ID: 10945239
[TBL] [Abstract][Full Text] [Related]
13. Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
Tertov VV; Sobenin IA; Orekhov AN
Clin Chem; 1995 Jul; 41(7):1018-21. PubMed ID: 7600681
[TBL] [Abstract][Full Text] [Related]
14. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
Sobenin IA; Tertov VV; Koschinsky T; Bünting CE; Slavina ES; Dedov II; Orekhov AN
Atherosclerosis; 1993 Apr; 100(1):41-54. PubMed ID: 8318062
[TBL] [Abstract][Full Text] [Related]
15. LDL sialic acid content in patients with coronary artery disease.
Ruelland A; Gallou G; Legras B; Paillard F; Cloarec L
Clin Chim Acta; 1993 Nov; 221(1-2):127-33. PubMed ID: 8149630
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the electrophoretic mobility of lipoproteins and coronary heart disease.
Kökoğlu E; Süer S; Sönmez H; Uçişik N
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):109-16. PubMed ID: 8824936
[TBL] [Abstract][Full Text] [Related]
17. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Tertov VV; Orekhov AN
Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
[TBL] [Abstract][Full Text] [Related]
19. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of low density lipoprotein isolated from circulating immune complexes.
Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
